Moderna Stock: Everything You Need To Know

Moderna is a biotechnology company founded in Cambridge, Massachusetts, in 2010. 

It focuses on developing messenger RNA (mRNA) therapeutics designed to treat diseases by modifying DNA instructions for cells to create disease-targeting proteins.

Moderna entered the public lexicon due to the FDA’s emergency use authorization and a rapid rollout of its Covid-19 vaccine.

Moderna Fundamentals

Moderna stock went public in 2018 and hovered between $15 to $20 till it took off in 2020.

Market Capitalization: $64.657B 

Market capitalization measures the company’s worth based on the number of issued shares at the current market share price.

PE Ratio: 8.9 

This ratio is a measure of how expensive a company’s stock is when compared to other companies.

You must compare PE ratios within the same industry to understand whether the company stock will generate a good return as part of your portfolio. 

Swipe Up

for more finance, business, and real estate advice

Read More

Your Long-Term Health: A (Financially) Valuable Investment

Jobs That Pay 100 an Hour (or More) and Can Be Done Remotely?